[12] [13] A comprehensive 2017 meta-analysis published in Diabetes Care examined data from over 60,000 patients and found no statistically significant increased risk of pancreatitis with GLP-1 agonists versus comparators
Colhoun, MD, of the Institute of Genetics and Cancer, The University of Edinburgh, Scotland, UK, told Medscape Medical News
Then you don't start the program and that's a good outcome
There have been extensive animal-based studies conducted on the functioning of IGF-1 in the body
In aesthetic and reconstructive surgery, rapid weight loss induced by these agents has raised concerns regarding facial volume depletion, skin laxity, and impaired wound healing
Laboratory studies investigate its role in IGF-1 signaling, body composition, and muscle metabolism